Blood test for pancreas function in chronic pancreatitis
Part of Digestive system clinical trials.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had at least 2 attacks of acute pancreatitis or have chronic pancreatitis (mild or moderate scarring of the pancreas).
- Your fecal elastase (a stool test for pancreas function) was 50 or higher in the last year.
- You are not allergic to pancreatic enzyme replacement therapy or the test itself.
- You are not taking certain medications (like orlistat or GLP-1 receptor agonists) that affect fat absorption.
- You have not had pancreatic enzyme replacement therapy for more than 5 days in the last month, and no recent acute pancreatitis attack (within 90 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study uses a special blood-sugar test (a mixed meal) to better diagnose and understand diabetes related to pancreatic cancer or chronic pancreatitis, and to compare it with other diabetes types. It may help researchers find clearer ways to tell these diabetes causes apart and understand how they work.
This study tests a protein drink with digestive enzymes for people with chronic pancreatitis who are underweight. It aims to help improve nutrition and weight.
This study tests a new blood test that uses epigenetics (chemical markers on DNA) to help diagnose pancreatic cancer. Researchers want to see if this test can accurately identify pancreatic cancer in people who have had it or are at high risk for developing it.
This study looks at how chronic pancreatitis affects blood sugar and digestion. It tests if your body makes enough enzymes and how your sugar control changes over time.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.